These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 37288718)

  • 21. Source and exploration of the peptides used to construct peptide-drug conjugates.
    Zhou J; Li Y; Huang W; Shi W; Qian H
    Eur J Med Chem; 2021 Nov; 224():113712. PubMed ID: 34303870
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recent Advances and Trends in Chemical CPP-Drug Conjugation Techniques.
    Gayraud F; Klußmann M; Neundorf I
    Molecules; 2021 Mar; 26(6):. PubMed ID: 33805680
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Parallel synthesis and screening of peptide conjugates.
    Dirksen A; Madsen M; Dello Iacono G; Matin MJ; Bacica M; Stanković N; Callans S; Bhat A
    Bioconjug Chem; 2014 Jun; 25(6):1052-60. PubMed ID: 24824568
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multivalent protein-drug conjugates - An emerging strategy for the upgraded precision and efficiency of drug delivery to cancer cells.
    Porębska N; Ciura K; Chorążewska A; Zakrzewska M; Otlewski J; Opaliński Ł
    Biotechnol Adv; 2023 Oct; 67():108213. PubMed ID: 37453463
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficient and Short Method for Conjugation of 1-Nitro-9-Aminoacridine to Important Peptidyl Fragments by a Solid Support Synthesis.
    Lahutta M
    Chem Biodivers; 2021 Jan; 18(1):e2000702. PubMed ID: 33205910
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Peptides as a platform for targeted therapeutics for cancer: peptide-drug conjugates (PDCs).
    Cooper BM; Iegre J; O' Donovan DH; Ölwegård Halvarsson M; Spring DR
    Chem Soc Rev; 2021 Feb; 50(3):1480-1494. PubMed ID: 33346298
    [TBL] [Abstract][Full Text] [Related]  

  • 27. On the design principles of peptide-drug conjugates for targeted drug delivery to the malignant tumor site.
    Vrettos EI; Mező G; Tzakos AG
    Beilstein J Org Chem; 2018; 14():930-954. PubMed ID: 29765474
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Controlled release of free doxorubicin from peptide-drug conjugates by drug loading.
    Chen Z; Zhang P; Cheetham AG; Moon JH; Moxley JW; Lin YA; Cui H
    J Control Release; 2014 Oct; 191():123-30. PubMed ID: 24892976
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeted in situ self-assembly augments peptide drug conjugate cell-entry efficiency.
    Wang MD; Hou DY; Lv GT; Li RX; Hu XJ; Wang ZJ; Zhang NY; Yi L; Xu WH; Wang H
    Biomaterials; 2021 Nov; 278():121139. PubMed ID: 34624753
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Peptide-Drug Conjugates: Design, Chemistry, and Drug Delivery System as a Novel Cancer Theranostic.
    Rizvi SFA; Zhang L; Zhang H; Fang Q
    ACS Pharmacol Transl Sci; 2024 Feb; 7(2):309-334. PubMed ID: 38357281
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel synovial targeting peptide-sinomenine conjugates as a potential strategy for the treatment of rheumatoid arthritis.
    Zhang T; Ouyang X; Gou S; Zhang Y; Yan N; Chang L; Li B; Zhang F; Liu H; Ni J
    Int J Pharm; 2022 Apr; 617():121628. PubMed ID: 35245636
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antibody-Assisted Delivery of a Peptide-Drug Conjugate for Targeted Cancer Therapy.
    Kim H; Hwang D; Choi M; Lee S; Kang S; Lee Y; Kim S; Chung J; Jon S
    Mol Pharm; 2019 Jan; 16(1):165-172. PubMed ID: 30521347
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of Linker-Drug Properties and Conjugation Site on the Physical Stability of ADCs.
    Mills BJ; Kruger T; Bruncko M; Zhang X; Jameel F
    J Pharm Sci; 2020 May; 109(5):1662-1672. PubMed ID: 32027921
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of bioactive gemcitabine-D-Lys
    Sayyad N; Vrettos EI; Karampelas T; Chatzigiannis CM; Spyridaki K; Liapakis G; Tamvakopoulos C; Tzakos AG
    Eur J Med Chem; 2019 Mar; 166():256-266. PubMed ID: 30716713
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Liposome-ligand conjugates: a review on the current state of art.
    Eroğlu İ; İbrahim M
    J Drug Target; 2020 Mar; 28(3):225-244. PubMed ID: 31339374
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Site-Specific Quantitation of Drug Conjugations on Antibody-Drug Conjugates (ADCs) Using a Protease-Assisted Drug Deconjugation and Linker-like Labeling (PADDLL) Method.
    Yang X; Seol H; Lin W; Xu X; Shen B; Qiu H; Li N
    Anal Chem; 2021 Jul; 93(27):9549-9558. PubMed ID: 34196532
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enabling Multiple Conjugation to Oligonucleotides Using "Click Cycles".
    Jezowska M; Honcharenko D; Ghidini A; Strömberg R; Honcharenko M
    Bioconjug Chem; 2016 Nov; 27(11):2620-2628. PubMed ID: 27756130
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Peptide-mediated targeted drug delivery.
    Majumdar S; Siahaan TJ
    Med Res Rev; 2012 May; 32(3):637-58. PubMed ID: 20814957
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chemical Biology Approaches toward Precise Structure Control of IgG-Based Antibody-Oligonucleotide Conjugates.
    Shen L; Wu Y; Xie W; Chen G; Xing H
    Chembiochem; 2023 May; 24(9):e202300077. PubMed ID: 36892014
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Research advances in peptide‒drug conjugates.
    Gong L; Zhao H; Liu Y; Wu H; Liu C; Chang S; Chen L; Jin M; Wang Q; Gao Z; Huang W
    Acta Pharm Sin B; 2023 Sep; 13(9):3659-3677. PubMed ID: 37719380
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.